Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of BAY 98-7196 intravaginal ring dose combinations in women with symptomatic endometriosis
2013-005090-53Phase 2Completed
- Sponsor
- Bayer
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anastrozole + levonorgestrel, anastrozole, avatrombopag and leuprolide in endometriosis (6 arms), sponsored by Bayer. Primary endpoint: Primary efficacy endpoint. Started Jul 2014; status: completed.
02
Drugs
anastrozole + levonorgestrelanastrozoleavatrombopagleuprolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2013-005090-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005090-53.